Quantifying the 5-ht1a agonist action of buspirone in man

Psychopharmacology

Volumn 158, Issue 3, 2001, Pages 224-229

  Sharma, Brijesh C ^a   Bhasin, Deepak K ^a   Makharia, Gobind ^a   Chhabra, Mohinish ^a   Vaiphei, Kim ^a   Bhatti, Harinderpal S ^a   Singh, Kartar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

5 HT1A receptor; Buspirone; Pindolol; Prolactin

Indexed keywords

BUSPIRONE; PINDOLOL; PROLACTIN; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; PLACEBO; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HUMAN; MALE; NONPARAMETRIC TEST; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SECRETION; SINGLE BLIND PROCEDURE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; HORMONE SENSITIVITY; NEUROENDOCRINOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; QUANTITATIVE ASSAY; SEROTONINERGIC SYSTEM;

ADOLESCENT; ADULT; AREA UNDER CURVE; BUSPIRONE; CROSS-OVER STUDIES; HUMANS; MALE; PINDOLOL; PROLACTIN; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC;

EID: 0034746985     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100881     Document Type: Article

References (39)

1. α-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers
2. Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers
3. The effects of gepirone on neuroendocrine function and temperature in humans
4. Possible upregulation of hypothalamic 5-hydroxytryp-tamine receptors in patients with postviral fatigue syndrome
5. Blockade of alpha2 adrenorecep-tors by 1-(pyrimidinyl)- piperazine (Pmp) in vivo and its relationship to the activity of buspirone
6. Buspirone challenge: Preliminary evidence for a role for central 5-HT1A receptor function in impulsive aggressive behaviour in humans
7. The reproducibility of the prolactin response to buspirone: Relationship to the menstrual cycle
8. Buspirone: Review of its pharmacology and current perspectives on its mechanism of action
9. Effect of ritanserin, a specific 5-HT2 antagonist on prolactin secretion in normal subjects and in different hyperprolactinaemic conditions
10. Metabolism and disposition of buspirone
11. Metergoline abolishes the prolactin response to buspirone
12. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?
13. Functional correlates of serotonin 5-HT1 recognition sites
14. Evidence for down regulation of hypothalamic 5-hydroxytryptamine receptor function in endurance-trained athletes
15. A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects
16. 1A receptor mediated effects of buspirone, gepirone and ipsapirone
17. Clinical profile of buspirone
18. Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on des-imipramine-induced pituitary hormone stimulation in humans. I Prolactin
19. Pharmacology of the hypothermic response to 5-HT1A receptor activation in humans
20. Prolactin response to buspirone challenge in the presence of dopami-nergic blockade
21. Dopamine receptor antagonism by the novel anti-anxiety drug buspirone
22. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man
23. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects
24. Effect of pindolol on hormone secretion and body temperature: Partial agonist effects
25. An effect of antidepressants on neuroendocrine axis in humans
26. The effect of buspirone on prolactin and growth hormone secretion in man
27. Neuroendocrine effects of buspirone: Mediation by dopaminergic and serotonergic mechanism
28. Effect of buspirone on prolactin secretion is not mediated by 5-HT-1a receptor stimulation
29. Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist, in humans
30. Neuroendocrine effects of buspirone
31. 1A receptor involvement in the control of prolactin secretion in man
32. Effect of pindolol on the prolactin response to d-fenfluramine
33. α-Blocker binding to human 5-HT(1A) receptors in vivo and in vitro: Implications for antidepressant therapy
34. Clinical effects of the 5-HT1A partial agonists in depression. A composite analysis of buspirone in the treatment of depression
35. Increased prolactin response to buspirone in chronic fatigue syndrome
36. 5-HT1A receptor anxiolytics
37. The involvement of subtypes of the 5-HT1 receptor and of catecholamine systems in the behavioural response to 8-hydroxy-2-(di-n-propyl-amino) tetralin
38. Neuroendocrine probes of seroto-nergic function: A critical review
39. Serotonin receptors, buspirone and premenstrual syndrome